Causes: Health, Pediatrics Research
Mission: Cure JM Foundation's mission is to find a cure for Juvenile Myositis and improve the lives of families affected by JM.
Results: In 2021, we demonstrated progress in three areas important to our families: Research, Patient Services, and Financial Stewardship. In 2021, we invested $5M in research to advance new treatments for JM, including clinical trials and partnerships with the biotech industry and the NIH. We also supported our patients by providing vital resources and connections for over 3,000 patients and families and funding four Centers of Excellence to advance JM research and deliver the highest quality of care to patients. And finally, we demonstrated excellent financial stewardship, being recognized with awards for its public accountability, program effectiveness and cost effectiveness. Since inception, Cure JM has invested more than 90% of contributions directly into research and programs to move our mission forward. Since inception, Cure JM has invested over $19 million to find better treatments and improve the care for children with JM.
Target demographics: All those battling Juvenile Myositis
Direct beneficiaries per year: 3,000 families and patients
Geographic areas served: the United States and worldwide
Programs: Cure JM is the largest global funder of Juvenile Myositis research and programs. Since inception, we have funded over $19 million in research, resulting in more than 190 published manuscripts to treatments and advance care for Juvenile Myositis.
Mission: Cure JM Foundation's mission is to find a cure for Juvenile Myositis and improve the lives of families affected by JM.
Results: In 2021, we demonstrated progress in three areas important to our families: Research, Patient Services, and Financial Stewardship. In 2021, we invested $5M in research to advance new treatments for JM, including clinical trials and partnerships with the biotech industry and the NIH. We also supported our patients by providing vital resources and connections for over 3,000 patients and families and funding four Centers of Excellence to advance JM research and deliver the highest quality of care to patients. And finally, we demonstrated excellent financial stewardship, being recognized with awards for its public accountability, program effectiveness and cost effectiveness. Since inception, Cure JM has invested more than 90% of contributions directly into research and programs to move our mission forward. Since inception, Cure JM has invested over $19 million to find better treatments and improve the care for children with JM.
Target demographics: All those battling Juvenile Myositis
Direct beneficiaries per year: 3,000 families and patients
Geographic areas served: the United States and worldwide
Programs: Cure JM is the largest global funder of Juvenile Myositis research and programs. Since inception, we have funded over $19 million in research, resulting in more than 190 published manuscripts to treatments and advance care for Juvenile Myositis.
Health
Leesburg
